As the world’s largest market, the U.S. is a critically important opportunity for companies, but success requires a detailed knowledge of the complex regulatory, access and payer landscapes, as well as keeping up with the impact of U.S. policy changes. The following Executive Summary highlights the...

Solomon Page brought together pharmaceutical and biotech leaders for a roundtable discussion, Emerging Models of Interaction, to discuss new models of engagement—both externally and internally—as a result of COVID-19. The conversation, chaired by Luigi Frezza, featured current and future digital...